The Microbiota-Gut-Brain Axis: Clinical Applications in Obesity and Type 2 Diabetes
Rev. invest. clín
;
74(6): 302-313, Nov.-Dec. 2022. graf
Article
Dans Anglais
|
LILACS-Express
| LILACS
| ID: biblio-1431819
ABSTRACT
ABSTRACT Recent investigations highlight the importance of the gut microbiota and bacteria-derived metabolites as key components in obesity and metabolic health. The microbiota-gut-brain axis presents promising targets for future obesity treatments and prevention. However, the current state of evidence and existing clinical applications of the microbiota-gut-brain axis have yet to be summarized in a thorough review. Therefore, we sought to examine current evidence on the effect of lifestyle, dietary, pharmacological, and surgical interventions on the microbiota-gut-brain axis. In addition, this review highlights potential next steps in research toward characterizing the role of the microbiota-gut-brain axis in metabolic health, along with possible interventions to address obesity.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
langue:
Anglais
Texte intégral:
Rev. invest. clín
Thème du journal:
Médicament
Année:
2022
Type:
Article
Pays d'affiliation:
États-Unis d'Amérique
Institution/Pays d'affiliation:
University of New Hampshire/US
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS